Example collocations logo

Treatments in sentence

516 examples of Treatments in a sentence

The federal Agency for Healthcare Research and Quality, responsible for assessing the efficacy of medical treatments, has led a precarious existence under the gaze, and political contributions, of medical specialists.
In lieu of effective treatments, controlling the spread of C. auris becomes all the more critical.
Nor does it include the drop in living standards from the loss of life-enhancing treatments – for example, knee or hip replacements, cancer treatment, and caesarean sections – that rely on antibiotics to prevent infections.
The broad-brush research we conducted shows that such treatments – many of which would not be possible without effective antibiotics – add around 4% of benefit in terms of GDP.
Getting Anxiety RightNEW YORK – When researchers want to evaluate the efficacy of new anxiety treatments, the traditional approach is to study how rats or mice behave in uncomfortable or stressful situations.
Neither patients nor their therapists consider the available options – including benzodiazepines like Valium and selective serotonin reuptake inhibitors like Prozac or Zoloft – as adequate treatments for anxiety.
Most treatments based on studies using mice or rats do make anxiety disorders easier to live with.
But, because the treatments do not directly address conscious brain processes, the anxiety itself does not always go away.
If treatments are to become more effective, our approaches will need to become more nuanced.
Despite this revelation, treatments for MND are still severely lacking.
If those funds are to support effective treatments, they should be channeled into further clinical trials, including of stem cells and gene therapies.
These diseases often lack effective preventative or curative vaccines or medicines, or the treatments that are available are too costly for the impoverished populations.
Precision medicine – which should not be confused with personalized medicine – describes a rules-based process by which standardized treatments with predictable outcomes are applied to known health conditions.
The sick could go “private” to secure life-extending treatments that the state is denying them.
Nevertheless, Anita Silvers, a philosopher at San Francisco State University and a disability scholar and activist, has described such treatments as “tyranny of the normal,” aimed at adjusting the deaf to a world designed by the hearing, ultimately implying the inferiority of deafness.
Given that there are no vaccines or drug treatments for illnesses like dengue fever and West Nile virus, and that treatments for diseases like malaria are difficult to access in many at-risk areas, more effective mechanisms for controlling mosquito populations are desperately needed.
Well over a billion people still do not have access to treatments for potentially debilitating conditions that cost less than $0.50 per person to deliver.
If the disorder has multiple causes, then there should be multiple treatments.
Because of the misuse and overuse of antibiotics, common infections such as pneumonia and tuberculosis are becoming increasingly resistant to existing treatments; in some cases, they have become completely immune.
Though several experimental treatments and at least two candidate vaccines had been in development when Ebola emerged unexpectedly early this year, progress had stalled well before any were deemed ready to be tested in humans.
In order to accelerate progress, governance of the clinical trials must be transparent, and all knowledge about the disease, including developments regarding potential treatments and vaccines, must be shared openly – imperatives that will require strong public-health leadership in both the Mano River countries and the developed world.
Moreover, with support from the World Health Organization, at least one international platform for clinical trials has been created to assess the safety and efficacy of experimental Ebola treatments, as well as to establish scientific and ethical standards of care.
Running clinical trials under the auspices of affected countries’ health ministries and the WHO – with full transparency in terms of processes and outcomes – would enable the relevant authorities to make timely and informed decisions regarding which treatments and vaccines to investigate further and when to deploy them.
They must share with those at the front lines of the battle information about diseases’ natural history, modes of transmission, and risk factors, as well as preclinical data on – and clinical responses to – experimental treatments.
Naturally, individual cases dictate which tests and treatments are best, but an additional concern about frequent screenings is the problem of false positives.
Moreover, the patients who receive these faulty diagnoses will usually receive further treatments, which often will have harmful consequences.
One of the study’s clearest takeaways is that we need to arm ourselves against the rising threat of drug and insecticide resistance by investing in research and development for next-generation antimalarial treatments.
And in Southeast Asia, some strains of the malaria parasite itself have begun to develop a resistance to artemisinin, the basic component in standard treatments.
The brain’s response to stress does not necessarily constitute “damage” per se and is amenable to reversal as well as prevention by treatments that include drugs, exercise, diet, and social support.
This can happen when doctors do not know whether a proposed treatment will do more harm than good, or when they are in doubt about which of two treatments is more likely to cure the patient.
BackNext